Amateur cyclists are attempting the full Tour de France route in 21 days to raise money for Cure Leukaemia [1], [2].
This challenge, documented in the series “Riding for Survival,” highlights the physical recovery of blood-cancer survivors while seeking critical funding for medical research. The effort transforms one of the world's most grueling sporting events into a platform for patient advocacy.
The group is navigating the official route of the 113th Tour de France [5]. The journey begins in Barcelona and concludes on the Champs-Élysées in Paris [3], [4]. The cyclists are attempting to complete the distance across 21 stages [6].
Fundraising targets for the initiative are set at £1 million [1], which is approximately $1.36 million [2]. The riders are tackling a distance that sources place between 3,333 km [1] and 3,338 km [2].
Their journey coincides with the professional 2026 Tour de France, which is scheduled to take place from July 4 to July 26 [3]. The amateur team includes former blood-cancer patients who are using the ride to support others currently battling the disease [1], [2].
“Amateur cyclists are attempting the full Tour de France route in 21 days.”
By mirroring the professional Tour de France schedule and route, the 'Riding for Survival' team leverages the global visibility of the 113th edition of the race to amplify their fundraising efforts. The use of a docuseries format suggests a strategic move to maintain public engagement over the 21-day period, turning a physical feat into a sustained awareness campaign for blood-cancer survival and research.
